A recent clinical study, by pharmaceutical company Neuroderm, has highlighted the development of a new liquid form of Parkinson's drug levodopa.
This new liquid form of levodopa holds promise as a potential future treatment for advanced Parkinson's.
The study involved 16 people with advanced Parkinson's who were given continuous infusion of the drug under their skin from a pump worn on a belt.
The liquid levodopa was able to maintain stable, high levels of levodopa in the blood.
- See more at: http://www.parkinsons.org.uk/news/8-january-2015/promising-results-new-liquid-form-levodopa#sthash.REDUwmfT.dpuf